121 related articles for article (PubMed ID: 9600271)
1. Insulin receptor-deficient cells as a new tool for dissecting complex interplay in insulin and insulin-like growth factors.
Lamothe B; Baudry A; Christoffersen CT; De Meyts P; Jami J; Bucchini D; Joshi RL
FEBS Lett; 1998 Apr; 426(3):381-5. PubMed ID: 9600271
[TBL] [Abstract][Full Text] [Related]
2. IGF-1 receptor as an alternative receptor for metabolic signaling in insulin receptor-deficient muscle cells.
Baudry A; Lamothe B; Bucchini D; Jami J; Montarras D; Pinset C; Joshi RL
FEBS Lett; 2001 Jan; 488(3):174-8. PubMed ID: 11163767
[TBL] [Abstract][Full Text] [Related]
3. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts.
Takahashi Y; Tobe K; Kadowaki H; Katsumata D; Fukushima Y; Yazaki Y; Akanuma Y; Kadowaki T
Endocrinology; 1997 Feb; 138(2):741-50. PubMed ID: 9003010
[TBL] [Abstract][Full Text] [Related]
4. The differential effects of pp120 (Ceacam 1) on the mitogenic action of insulin and insulin-like growth factor 1 are regulated by the nonconserved tyrosine 1316 in the insulin receptor.
Soni P; Lakkis M; Poy MN; Fernström MA; Najjar SM
Mol Cell Biol; 2000 Jun; 20(11):3896-905. PubMed ID: 10805733
[TBL] [Abstract][Full Text] [Related]
5. Insulin receptor (IR) pathway hyperactivity in IGF-IR null cells and suppression of downstream growth signaling using the dual IGF-IR/IR inhibitor, BMS-754807.
Dinchuk JE; Cao C; Huang F; Reeves KA; Wang J; Myers F; Cantor GH; Zhou X; Attar RM; Gottardis M; Carboni JM
Endocrinology; 2010 Sep; 151(9):4123-32. PubMed ID: 20610571
[TBL] [Abstract][Full Text] [Related]
6. Signal transduction by a chimeric insulin-like growth factor-1 (IGF-1) receptor having the carboxyl-terminal domain of the insulin receptor.
Tartare S; Mothe I; Kowalski-Chauvel A; Breittmayer JP; Ballotti R; Van Obberghen E
J Biol Chem; 1994 Apr; 269(15):11449-55. PubMed ID: 8157675
[TBL] [Abstract][Full Text] [Related]
7. Physiological concentrations of insulin induce cellular desensitization to the mitogenic effects of insulin-like growth factor I.
Conover CA; Clarkson JT; Bale LK
Diabetes; 1994 Sep; 43(9):1130-7. PubMed ID: 8070613
[TBL] [Abstract][Full Text] [Related]
8. Insulin and the insulin-like growth factors I and II are mitogenic to cultured rat sciatic nerve segments and stimulate [3H]thymidine incorporation through their respective receptors.
Fex Svenningsen A; Kanje M
Glia; 1996 Sep; 18(1):68-72. PubMed ID: 8891693
[TBL] [Abstract][Full Text] [Related]
9. Differential signaling activation by insulin and insulin-like growth factors I and II upon binding to insulin receptor isoform A.
Sacco A; Morcavallo A; Pandini G; Vigneri R; Belfiore A
Endocrinology; 2009 Aug; 150(8):3594-602. PubMed ID: 19443570
[TBL] [Abstract][Full Text] [Related]
10. Direct evidence that the insulin receptor mediates a mitogenic response in cultured human fibroblasts.
Conover A; Hintz RL; Rosenfeld RG
Horm Metab Res; 1989 Feb; 21(2):59-63. PubMed ID: 2722129
[TBL] [Abstract][Full Text] [Related]
11. Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors.
Di Cola G; Cool MH; Accili D
J Clin Invest; 1997 May; 99(10):2538-44. PubMed ID: 9153298
[TBL] [Abstract][Full Text] [Related]
12. Insulin and insulin-like growth factor-I receptors similarly stimulate deoxyribonucleic acid synthesis despite differences in cellular protein tyrosine phosphorylation.
Mastick CC; Kato H; Roberts CT; LeRoith D; Saltiel AR
Endocrinology; 1994 Jul; 135(1):214-22. PubMed ID: 7516864
[TBL] [Abstract][Full Text] [Related]
13. Selective insulin resistance in the polycystic ovary syndrome.
Book CB; Dunaif A
J Clin Endocrinol Metab; 1999 Sep; 84(9):3110-6. PubMed ID: 10487672
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor I signalling through heterodimers of insulin and insulin-like growth factor I receptors.
Takata Y; Kobayashi M
Diabete Metab; 1994; 20(1):31-6. PubMed ID: 8056133
[TBL] [Abstract][Full Text] [Related]
15. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
[TBL] [Abstract][Full Text] [Related]
16. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.
Mur C; Valverde AM; Kahn CR; Benito M
Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675
[TBL] [Abstract][Full Text] [Related]
17. Insulin-Insulin-like Growth Factors Hybrids as Molecular Probes of Hormone:Receptor Binding Specificity.
Křížková K; Chrudinová M; Povalová A; Selicharová I; Collinsová M; Vaněk V; Brzozowski AM; Jiráček J; Žáková L
Biochemistry; 2016 May; 55(21):2903-13. PubMed ID: 27171135
[TBL] [Abstract][Full Text] [Related]
18. The metabolic and mitogenic effects of both insulin and insulin-like growth factor are enhanced by transfection of insulin receptors into NIH3T3 fibroblasts.
Hofmann C; Goldfine ID; Whittaker J
J Biol Chem; 1989 May; 264(15):8606-11. PubMed ID: 2656686
[TBL] [Abstract][Full Text] [Related]
19. Glucosamine induces resistance to insulin-like growth factor I (IGF-I) and insulin in Hep G2 cell cultures: biological significance of IGF-I/insulin hybrid receptors.
Sakai K; Clemmons DR
Endocrinology; 2003 Jun; 144(6):2388-95. PubMed ID: 12746299
[TBL] [Abstract][Full Text] [Related]
20. Insulin and IGF-I action on insulin receptors, IGF-I receptors, and hybrid insulin/IGF-I receptors in vascular smooth muscle cells.
Johansson GS; Arnqvist HJ
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1124-30. PubMed ID: 16803852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
